Cidara Therapeutics, Inc. Contracts & Agreements

License and Technology Agreement, dated April 23, 2024, by and between the Registrant and Janssen Pharmaceuticals, Inc (Filed With SEC on August 13, 2024)

2020 Inducement Plan of the Registrant, as amended (Filed With SEC on August 13, 2024)

Cidara Therapeutics, Inc. 2024 Equity Incentive Plan, Form of Grant Notice, Stock Option Agreement and Notice of Exercise, and Form of Restricted Stock Unit Grant Notice and... (Filed With SEC on July 18, 2024)

Asset Purchase Agreement, dated April 24, 2024, by and between Cidara Therapeutics, Inc. and NAPP Pharmaceutical Group Limited (Filed With SEC on April 29, 2024)

Assignment and Novation Agreement, dated April 24, 2024, by and between Cidara Therapeutics, Inc. and NAPP Pharmaceutical Group Limited (Filed With SEC on April 29, 2024)

First Amendment to Melinta License Agreement, dated April 23, 2024, by and between Melinta Therapeutics, LLC and Cidara Therapeutics, Inc (Filed With SEC on April 29, 2024)

Securities Purchase Agreement, dated April 23, 2024, by and among Cidara Therapeutics, Inc. and the purchasers named therein (Filed With SEC on April 24, 2024)

Form of Support Agreement (Filed With SEC on April 24, 2024)

Non-Employee Director Compensation Policy, as amended (Filed With SEC on April 22, 2024)

Seventh Amendment to Lease by and between the Registrant and Nancy Ridge Technology Center, L.P., dated April 20, 2023 (Filed With SEC on May 11, 2023)

Non-Employee Director Compensation Policy, as amended (Filed With SEC on March 23, 2023)

Underwriting Agreement, dated March 3, 2023, by and between Cidara Therapeutics, Inc. and Cantor Fitzgerald & Co. (Common Stock) (Filed With SEC on March 6, 2023)

Underwriting Agreement, dated March 3, 2023, by and between Cidara Therapeutics, Inc. and Cantor Fitzgerald & Co. (Series X Convertible Preferred Stock) (Filed With SEC on March 6, 2023)

License Agreement by and between the Registrant and Melinta Therapeutics, LLC, dated July 26, 2022 (Filed With SEC on November 3, 2022)

Employment offer letter between the Registrant and Taylor Sandison, dated March 22, 2017 (Filed With SEC on November 3, 2022)

Employment offer letter between the Registrant and Shane M. Ward, dated August 17, 2021 (Filed With SEC on November 3, 2022)

Employment offer letter between the Registrant and Preetam Shah, dated August 19, 2021 (Filed With SEC on November 3, 2022)

Fifth Amendment to Loan and Security Agreement by and between the Registrant and Pacific Western Bank, dated April 4, 2022 (Filed With SEC on August 9, 2022)

Letter Agreement by and between the Registrant and Mundipharma Medical Company, dated April 20, 2022 (Filed With SEC on August 9, 2022)

Non-Employee Director Compensation Policy, as amended (Filed With SEC on March 7, 2022)

Fifth Amendment to Lease by and between the Registrant and Nancy Ridge Technology Center (Filed With SEC on March 7, 2022)

Underwriting Agreement, dated October 7, 2021, by and between Cidara Therapeutics, Inc. and Cantor Fitzgerald & Co. (Common Stock) (Filed With SEC on October 8, 2021)

Underwriting Agreement, dated October 7, 2021, by and between Cidara Therapeutics, Inc. and Cantor Fitzgerald & Co. (Series X Convertible Preferred Stock) (Filed With SEC on October 8, 2021)

Form of Amended and Restated Employment Agreement by and between the Registrant and its executive officers (Filed With SEC on August 12, 2021)

Sixth Amendment to Lease by and between the Registrant and Nancy Ridge Technology Center, L.P., dated July 14, 2021 (Filed With SEC on August 12, 2021)

Fourth Amendment to Loan and Security Agreement by and between the Registrant and Pacific Western Bank, dated March 16, 2021 (Filed With SEC on May 13, 2021)

Third Amendment to Loan and Security Agreement, by and between the Registrant and Pacific Western Bank, dated November 5, 2019 (Filed With SEC on February 25, 2021)

Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the Cidara (Filed With SEC on December 7, 2020)

Form of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise under the Cidara Therapeutics, Inc. 2020 Inducement Incentive Plan (Filed With SEC on December 7, 2020)

Cidara Therapeutics, Inc. 2020 Inducement Incentive Plan (Filed With SEC on December 7, 2020)

Description of the Registrant's Securities (Filed With SEC on August 13, 2020)

Non-Employee Director Compensation Policy, as amended (Filed With SEC on March 4, 2020)

Description of the Registrant's Securities (Filed With SEC on March 4, 2020)

Investment Agreement, dated January 9, 2020, by and among the Company and the signatories thereto (Filed With SEC on January 10, 2020)

Stock Purchase Agreement, dated September 3, 2019, by and between the Registrant and Mundipharma AG (Filed With SEC on November 8, 2019)

Collaboration and License Agreement, dated September 3, 2019, by and between the Registrant and Mundipharma Medical Company (Filed With SEC on November 8, 2019)

Exchange Agreement, dated March 22, 2019, between the Company and Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P., Biotechnology Value Trading Fund OS, L.P. and... (Filed With SEC on March 22, 2019)

First Amendment to Loan and Security Agreement, by and between the Registrant and Pacific Western Bank, dated June 13, 2018 (Filed With SEC on August 9, 2018)

Second Amendment to Loan and Security Agreement by and between Cidara Therapeutics, Inc. and Pacific Western Bank, dated July 27, 2018 (Filed With SEC on July 31, 2018)

Fourth Amendment to Lease by and between Cidara Therapeutics, Inc. and Nancy Ridge Technology Center, L.P., dated June 29, 2018 (Filed With SEC on July 3, 2018)

Form of Common Stock Purchase Warrant for First Private Placement (Filed With SEC on May 21, 2018)

Form of Common Stock Purchase Warrant for Second Private Placement (Filed With SEC on May 21, 2018)

Subscription Agreement (Filed With SEC on May 21, 2018)

Placement Agency Agreement (Filed With SEC on May 21, 2018)

Securities Purchase Agreement, dated October 19, 2017, between the Company and the purchasers listed therein (Filed With SEC on October 20, 2017)

CIDARA THERAPEUTICS, INC. RESTRICTED STOCK UNIT GRANT NOTICE (2015 EQUITY INCENTIVE PLAN) (Filed With SEC on May 10, 2017)

Very truly yours,By:Jeffrey Stein, Ph.D. President and Chief Executive Officer (Filed With SEC on November 10, 2016)

2,475,248 Shares Cidara Therapeutics, Inc. UNDERWRITING AGREEMENT (Filed With SEC on October 7, 2016)

WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on October 3, 2016)

CIDARA THERAPEUTICS, INC. LOAN AND SECURITY AGREEMENT (Filed With SEC on October 3, 2016)

CONSULTING AND INDEPENDENT CONTRACTOR AGREEMENT (Filed With SEC on September 1, 2016)

CIDARA THERAPEUTICS, INC. BONUS PLAN Effective January 1, 2016 (Filed With SEC on March 18, 2016)

THIRD AMENDMENT TO LEASE DATED JULY 1, 2015 (Filed With SEC on November 16, 2015)

[Number of Shares] Cidara Therapeutics, Inc. UNDERWRITING AGREEMENT (Filed With SEC on April 6, 2015)

Additional abbreviations may also be used though not in the above list. (Filed With SEC on April 6, 2015)

CIDARA THERAPEUTICS, INC. 2015 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:MARCH 27, 2015 APPROVED BY THE STOCKHOLDERS:APRIL 1, 2015 IPO DATE: [],2015 (Filed With SEC on April 6, 2015)

CIDARA THERAPEUTICS, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS:MARCH 27, 2015 APPROVED BY THE STOCKHOLDERS:APRIL 1, 2015 (Filed With SEC on April 6, 2015)

CIDARA THERAPEUTICS, INC. BONUS PLAN EffectiveJanuary 1, 2015 (Filed With SEC on April 6, 2015)

CIDARA THERAPEUTICS, INC. LOAN AND SECURITY AGREEMENT (Filed With SEC on March 13, 2015)

CIDARA THERAPEUTICS, INC. SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT CIDARA THERAPEUTICS, INC. SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on March 13, 2015)

WARRANT TO PURCHASESTOCK (Filed With SEC on March 13, 2015)

INDEMNIFICATION AGREEMENT (Filed With SEC on March 13, 2015)

CIDARA THERAPEUTICS, INC. 2015 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: [], 2015 APPROVED BY THESTOCKHOLDERS: [], 2015 IPO DATE:[], 2015 (Filed With SEC on March 13, 2015)

CIDARA THERAPEUTICS, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS: [], 2015 APPROVED BY THESTOCKHOLDERS: [], 2015 (Filed With SEC on March 13, 2015)

CIDARA THERAPEUTICS, INC. 2013 STOCK OPTION AND GRANT PLAN (Filed With SEC on March 13, 2015)

CONSULTING AND INDEPENDENT CONTRACTOR AGREEMENT (Filed With SEC on March 13, 2015)

ADDENDUM TO ASSETPURCHASE AGREEMENT (Filed With SEC on March 13, 2015)

ASSET PURCHASE AGREEMENT ACQUISITION OF CERTAIN ASSETS OF SEACHAID PHARMACEUTICALS, INC. BY K2 THERAPEUTICS,INC. DATED AS OF MAY 30, 2014 TABLE OF CONTENTS (Filed With SEC on March 13, 2015)

SECOND AMENDMENT TO LEASE (Filed With SEC on March 13, 2015)

FIRST AMENDMENT TO LEASE (Filed With SEC on March 13, 2015)

AIR COMMERCIAL REAL ESTATE ASSOCIATION STANDARD INDUSTRIAL/COMMERCIAL MULTI-TENANT LEASE - NET (Filed With SEC on March 13, 2015)

Category

Industry

Companies

Contracts

Cidara Therapeutics, Inc. Contracts & Agreements